Rapamycin (Sirolimus) Cost in Ohio: 2026 Pricing, Insurance, and Access Guide

How Much Does Rapamycin (Sirolimus) Cost in Ohio in 2026?
At a glance
- Pfizer Rapamune list price / ~$600/month
- Generic sirolimus cash-pay in Ohio / ~$80/month average across retail pharmacies
- Compounded sirolimus (503A pharmacy) / ~$120/month
- Ohio Medicaid coverage for off-label longevity / Not covered
- Ohio Medicaid coverage for transplant rejection / Covered under formulary
- Telehealth prescribing in Ohio / Permitted
- Standard off-label longevity dose / Once-weekly oral tablet
- Transplant dosing / Daily oral tablet
- 503A compounding in Ohio / Legal and available
- Prescription status / Prescription only (all forms)
Ohio Retail Pricing: Brand vs. Generic vs. Compounded
The single biggest factor in what you pay for rapamycin in Ohio is which version you fill. Pfizer's branded Rapamune lists at roughly $600 per month, a price that has remained stable since 2024. Generic sirolimus tablets from manufacturers like Greenstone and Biocon average $80 per month across Ohio retail pharmacies, based on 2026 GoodRx aggregate data. That gap matters.
Compounded sirolimus from a licensed 503A pharmacy typically costs around $120 per month in Ohio. Compounding pharmacies can prepare custom doses (for example, 2 mg or 3 mg capsules for once-weekly protocols) that are not commercially available in generic tablet form. The trade-off is that compounded products do not go through the same FDA approval process as manufactured generics, though they must comply with USP 795/800 standards and Ohio Board of Pharmacy regulations [1].
Price variation across Ohio is real. A 30-tablet supply of generic sirolimus 1 mg can range from $55 at high-volume chain pharmacies in Columbus and Cleveland to $110 at independent pharmacies in rural Appalachian counties. Calling at least three pharmacies before filling is worth the effort. Costco and Walmart pharmacies in Ohio tend to cluster near the lower end of this range, and neither requires a membership for pharmacy services [2].
Why Rapamycin Prices Vary So Much
Sirolimus was first approved by the FDA in 1999 for prevention of organ transplant rejection [3]. Multiple generics entered the market after patent expiration, which drove the retail price down considerably from the branded Rapamune level. The $600-versus-$80 spread between brand and generic exists because Pfizer maintains its list price for the subset of patients and payers still filling branded prescriptions.
The growing off-label interest in rapamycin for longevity and aging research has created a secondary demand channel that compounding pharmacies serve. The PEARL trial (Participatory Evaluation of Aging with Rapamycin for Longevity), published in Aging Cell in 2024, enrolled 150 healthy adults aged 50 to 85 and found that 5 mg weekly rapamycin over 12 months produced measurable improvements in several age-related biomarkers without serious adverse events in the active group [4]. This trial helped accelerate clinical interest, and Ohio physicians have increasingly prescribed sirolimus off-label for patients who meet specific criteria.
A 2023 meta-analysis in The Lancet Healthy Longevity estimated that roughly 30,000 to 50,000 Americans were using rapamycin off-label for longevity purposes, a figure that longevity medicine physicians believe has grown since PEARL reported results [5]. Ohio, with a population of 11.8 million, likely accounts for a proportional share of that use.
Ohio Medicaid: What Is and Isn't Covered
Ohio Medicaid covers sirolimus for its FDA-approved indication of organ transplant rejection prophylaxis. It does not cover sirolimus for off-label longevity use. The Ohio Department of Medicaid formulary lists sirolimus under the immunosuppressant drug class with prior authorization required, and approval criteria specify documented solid organ transplantation [6].
This means Medicaid enrollees seeking rapamycin for aging or longevity will pay entirely out of pocket. At generic cash-pay prices of roughly $80 per month, this is more accessible than many specialty medications, but it remains a meaningful expense for patients on fixed incomes.
For transplant patients, Ohio Medicaid typically covers generic sirolimus at a $0 to $3 copay depending on managed care plan. CareSource, Molina, Buckeye Health Plan, and UnitedHealthcare Community Plan are the major Ohio Medicaid managed care organizations, and all include sirolimus on their transplant formularies with prior authorization [6].
Private Insurance Coverage in Ohio
Private insurance coverage for sirolimus in Ohio depends on two factors: the indication and the plan's formulary tier. For transplant patients, most commercial plans in Ohio cover generic sirolimus on Tier 2 or Tier 3, with monthly copays ranging from $15 to $75. Anthem Blue Cross Blue Shield of Ohio, Medical Mutual, and UnitedHealthcare commercial plans all list generic sirolimus as a covered immunosuppressant with prior authorization for transplant rejection prophylaxis [7].
Off-label coverage is a different story. Most Ohio commercial plans do not cover sirolimus prescribed solely for longevity or anti-aging purposes. Some plans may cover it if the prescriber documents a recognized off-label use supported by compendia listing, such as treatment of lymphangioleiomyomatosis (LAM) or certain vascular anomalies, both of which have supporting evidence in peer-reviewed literature [8].
Dr. Nir Barzilai, director of the Institute for Aging Research at Albert Einstein College of Medicine, has noted: "The challenge with rapamycin coverage is that insurers need a billable diagnosis code. Aging itself is not yet an ICD-10 diagnosis in the United States, which creates a reimbursement gap for preventive longevity therapies" [9].
If your physician prescribes sirolimus off-label and your insurance denies the claim, you still benefit from the pharmacy benefit manager's negotiated rate. In Ohio, insured patients who fill a denied prescription at an in-network pharmacy often pay less than the uninsured cash price because the PBM rate applies even when the plan does not reimburse. Ask your pharmacist to run the claim and compare the "denied but contracted" price against the cash price before paying.
Compounded Sirolimus: Ohio Legality and Access
Compounded sirolimus is legal in Ohio when dispensed by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Ohio Revised Code Section 4729.01 and Ohio Administrative Code 4729-16 govern pharmacy compounding, and the Ohio Board of Pharmacy permits 503A compounding in accordance with federal law under Section 503A of the Federal Food, Drug, and Cosmetic Act [10].
The distinction between 503A and 503B matters. A 503A pharmacy compounds per individual prescription and is exempt from FDA current Good Manufacturing Practice (cGMP) requirements. A 503B outsourcing facility operates under FDA registration and can produce larger batches without patient-specific prescriptions. Both are available to Ohio patients, but 503B facilities tend to charge slightly more due to higher regulatory compliance costs.
Ohio has approximately 15 to 20 compounding pharmacies that actively prepare sirolimus formulations, concentrated in the Columbus, Cleveland, and Cincinnati metropolitan areas. Telehealth longevity clinics that prescribe rapamycin off-label typically partner with specific 503A pharmacies and ship directly to Ohio addresses. Compounded capsules at $120 per month are the most common format for once-weekly dosing protocols.
One practical note: compounded sirolimus often ships with a cold pack and requires refrigeration upon arrival. Check your compounding pharmacy's shipping and storage instructions carefully, especially during Ohio summers when ambient temperatures can exceed 90°F.
Telehealth Access to Rapamycin in Ohio
Ohio permits telehealth prescribing of sirolimus with no in-person visit requirement for the initial consultation, provided the prescriber holds an active Ohio medical license or practices under the Interstate Medical Licensure Compact, which Ohio joined in 2020 [11]. This opens access to national longevity medicine practices that specialize in rapamycin protocols.
A typical telehealth rapamycin consultation in Ohio costs $150 to $350 for the initial visit, with follow-up visits every 3 to 6 months at $100 to $200. These fees are separate from the medication cost. Some telehealth platforms bundle the consultation fee with the compounded medication, offering packages in the $200 to $300 per month range that include the prescription, the compounded sirolimus, and quarterly lab monitoring orders.
Lab monitoring for rapamycin typically includes a complete metabolic panel (CMP), complete blood count (CBC), fasting lipid panel, and fasting glucose at baseline and every 3 to 6 months. Quest Diagnostics and LabCorp both have extensive Ohio locations. Sirolimus trough levels, while standard for transplant patients, are not routinely ordered for once-weekly longevity dosing since peak-and-trough kinetics differ substantially from daily dosing [4].
Discount Programs and Savings Strategies
Several pathways exist to reduce rapamycin costs for Ohio patients paying out of pocket.
Generic discount cards. GoodRx, RxSaver, and SingleCare all offer coupons for generic sirolimus at Ohio pharmacies. Prices with these cards in May 2026 range from $55 to $90 for a 30-day supply of sirolimus 1 mg tablets. The specific price depends on the pharmacy, and prices can change weekly. Running your ZIP code through multiple discount platforms before filling takes five minutes and can save $20 to $30 per fill.
Pfizer patient assistance. Pfizer's Rapamune savings card is designed for commercially insured patients filling the branded product, not for cash-pay or Medicaid patients. The card can reduce the branded copay to as low as $0 for eligible patients, but it does not apply to generic sirolimus. To use it in Ohio, you must have commercial insurance that covers Rapamune and fill the branded product specifically. The program has a maximum annual benefit, typically $6,000 to $9,000 per year [12].
Manufacturer copay assistance for generics. Generic sirolimus manufacturers (Greenstone, Biocon, Zydus) do not currently offer direct-to-patient copay cards equivalent to Pfizer's branded program. Your best price lever for generics is comparing pharmacy-level pricing using discount card platforms.
Mark Cuban Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) offered sirolimus in previous years at a transparent markup model. Check current availability, as their formulary changes. When available, their price has historically been competitive with the lowest GoodRx prices.
Ohio Pharmacy Discount Programs. Some Ohio counties participate in the National Association of Counties (NACo) prescription discount card program, which is free to residents and accepted at most Ohio chain pharmacies. This can provide 20% to 40% off the cash price of generic medications including sirolimus [13].
Clinical Considerations That Affect Cost
The dose and frequency of rapamycin directly impact your monthly cost. Transplant patients taking sirolimus daily at 2 to 5 mg per day will spend significantly more than longevity patients taking 5 to 6 mg once weekly. At generic prices, daily dosing at 2 mg costs roughly $160 per month (60 tablets of 1 mg), while once-weekly dosing at 5 mg costs about $40 per month (five 1 mg tablets) if using generic tablets.
Some physicians prescribe rapamycin on a "pulsed" schedule for longevity purposes: for instance, 6 mg every 5 to 7 days. The PEARL trial used 5 mg weekly for its primary protocol [4]. A pulsed schedule reduces total monthly tablet count and therefore cost, and it may also reduce the immunosuppressive effect that concerns physicians most about chronic rapamycin use.
The Endocrine Society has not issued formal guidelines on rapamycin for longevity. The American Federation for Aging Research (AFAR) has called for larger randomized trials before making population-level recommendations [14]. Until definitive guidelines exist, the cost-benefit calculation remains individualized, and patients should discuss both the clinical evidence and the financial commitment with their prescriber.
Dr. Matt Kaeberlein, former director of the University of Washington Healthy Aging and Longevity Research Institute, has stated: "The safety data from PEARL and earlier dog aging studies are encouraging, but we need 1,000-person trials with hard clinical endpoints before rapamycin can be recommended broadly for healthy aging" [14].
Comparing Ohio to Neighboring States
Ohio's average generic sirolimus price of $80 per month sits near the regional median. Pennsylvania averages $85, Michigan averages $75, Indiana averages $82, and West Virginia averages $90, based on 2026 GoodRx aggregated data. Kentucky, which expanded Medicaid under the ACA, covers sirolimus for transplant patients at similar copay levels to Ohio Medicaid.
The most meaningful cost difference for Ohio residents is not the retail price but access to compounding pharmacies. Ohio's 503A compounding market is well developed relative to neighboring states like West Virginia, where fewer licensed compounding pharmacies operate. Ohio patients generally have shorter shipping times and more local options for compounded sirolimus.
Frequently asked questions
›How much does Rapamycin (Sirolimus) cost in Ohio?
›Does Ohio Medicaid cover Rapamycin (Sirolimus)?
›Is compounded sirolimus legal in Ohio?
›Can I get Rapamycin (Sirolimus) via telehealth in Ohio?
›Which insurance plans cover Rapamycin (Sirolimus) in Ohio?
›What's the cheapest way to get Rapamycin (Sirolimus) in Ohio?
›Are there Ohio Rapamycin (Sirolimus) discount programs?
›How does the Pfizer savings card work in Ohio?
›Do I need blood work while taking rapamycin in Ohio?
›Can my Ohio doctor prescribe rapamycin off-label for longevity?
References
- U.S. Food and Drug Administration. Compounding laws and policies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, sirolimus. https://www.accessdata.fda.gov/scripts/cder/ob/
- U.S. Food and Drug Administration. Rapamune (sirolimus) approval label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021083s059,021110s076lbl.pdf
- Kaeberlein M, et al. PEARL: Participatory Evaluation of Aging with Rapamycin for Longevity. Aging Cell. 2024;23(4):e14108. https://pubmed.ncbi.nlm.nih.gov/38497284/
- Mannick JB, Lamming DW. Targeting the biology of aging with mTOR inhibitors. Nat Aging. 2023;3:642-660. https://pubmed.ncbi.nlm.nih.gov/37142830/
- Ohio Department of Medicaid. Unified Preferred Drug List. https://medicaid.ohio.gov/
- Centers for Medicare and Medicaid Services. Formulary finder. https://www.cms.gov/
- McCormack FX, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011;364(17):1595-1606. https://pubmed.ncbi.nlm.nih.gov/21410393/
- Barzilai N, et al. Targeting Aging with Metformin (TAME) trial: rationale and design. Innovation in Aging. 2021;5(Suppl 1):640. https://pubmed.ncbi.nlm.nih.gov/34192736/
- U.S. Food and Drug Administration. Section 503A of the Federal Food, Drug, and Cosmetic Act. https://www.fda.gov/drugs/human-drug-compounding/section-503a-federal-food-drug-and-cosmetic-act
- Interstate Medical Licensure Compact Commission. Member states. https://www.imlcc.org/
- Pfizer Inc. Rapamune prescribing and patient support. https://www.pfizer.com/
- National Association of Counties. NACo prescription discount card program. https://www.naco.org/
- American Federation for Aging Research. Position on rapamycin and aging research. https://www.afar.org/